Newsletters
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
Final CABP and HABP-VABP guidances from FDA; EU seeks to accelerate access to medicines
Dear All, Some regulatory updates today. From FDA, we have final versions of their CABP and HABP-VABP guidance documents. My …
NHS England Antibiotic Procurement Pilot: Call for applications!
Dear All, As has been discussed in recent newsletters (link), the UK National Institute for Health and Care Excellence (NICE) …
National Academies: Nominations sought for ad hoc committee on medical and economic impact of AMR
26 Aug 2020 update: The committe has been named and some additional project commentary posted. Go here for details. — …
Perspectives on restoring the antibiotic ecosystem: ACS ID, June 2020 issue
Dear All, The June issue of ACS Infectious Diseases (link) is entirely devoted to the perspectives on how we can …
Jobs (mostly in Denmark) supporting global implementation of National Action Plans
Dear All, As recently highlighted in the 2019 reports from the World Bank (Pulling Together to Beat Superbugs, link) and …
Novo REPAIR Impact Fund: Global call is open through 31 July 2020
Dear All, Sharpen your pencils! The Novo REPAIR Impact Fund has just opened its 2020 call for proposals. The focus …
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
Dear All (wonkish note alert — refresh your coffee before proceeding — with thanks to Kevin Outterson for co-authoring this …
Tender call: Global AMR R&D Hub seeks analyses of the market potential of four types of AMR products
Dear All, The G20-sponsored Global AMR R&D Hub (https://globalamrhub.org/) has recently published a call requesting proposals to estimate the market …
Virtual collaborations: JPIAMR’s Virtual Research Initiative; Global AMR Hub’s Dashboard
Dear All, If there is a silver lining to the dark cloud of COVID-19, it’s that we’re all becoming very …
From an IV arsenical to PO fexinidazole for Sleeping Sickness: A doctor’s dream
Dear All, As those of us who have had the privilege of standing at the bedside and delivering care know …
Timely guidelines, regularly updated: COVID-19, C. difficile, and beyond
Dear All, During the 18-19 Nov 2019 FDA-IDSA-NIAID-Pew workshop on ways to enhance antibacterial research (link), we spent some time …
WHO 2020 preclinical antibacterial pipeline data call
Dear All: As you will hopefully recall from November 2019, Theuretzbacher et al. published a review of the preclinical pipeline …
Movies to discover antibiotics by!
Dear All, Well, I think we can all agree that being grounded and shut away by COVID-19 is not exactly …
COVID-19 and bacterial infections / New webinars and meeting updates
Dear All: Three brief items for you today. First up: Perhaps like many of you, I’ve been wondering whether or …
COVID-19 R&D support: US (FDA, BARDA, NIAID), Europe (EMA, EC), and globally (BioCentury resource hub)
Dear All, And now for a change from our usually scheduled content! As you might expect, major agencies in the …
Pull incentives for antibiotics: How much and why? — A literature survey
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), The recent discussions of the NICE/NHS England pilot …
UK Antibiotic Subscription Pilot: Post-webinar FAQ document
Dear All, Kevin Outterson and I recently shared our analysis of the NICE/NHS England pilot of an antibiotic procurement subscription …
WHO consultancy: Create online e-learning on antimicrobial stewardship
Dear All, WHO today published a Request for Proposals (RFP) for a consultant to develop an online e-learning course on …
COVID-19 Insights from Carr, Gottlieb, McClellan / Global AMR R&D Hub Dynamic Dashboard
Dear All, Three things to share this afternoon. First, Alan Carr has published a newsletter (link) reporting the results from …
UK Antibiotic Subscription Pilot implies Pull Incentive of up to $4b across the G20
Note that there is a follow-up newsletter that covers a post-webinar FAQ. After reading this newsletter as introduction, please go …
